Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Renaissance Washington DC Downtown Hotel

Jan 13, 2014 8:30 AM - Jan 15, 2014 4:00 PM

999 Ninth Street NW, Washington, DC 20001

Pharmacovigilance and Risk Management Strategies 2014

Session 9, Part I – Real World Evidence: The Building Blocks

Session Chair(s)

Mariette  Boerstoel-Streefland, MD, MBA, MS

Mariette Boerstoel-Streefland, MD, MBA, MS

Senior Vice President, Worldwide Safety Officer

Bristol-Myers Squibb Company, United States

Session 9, Part I – Real World Evidence: The Building Blocks

Speaker(s)

Robert  Reynolds, DrSc, MSc, FISPE

PROTECT

Robert Reynolds, DrSc, MSc, FISPE

Pfizer Inc, United States

Vice President, Epidemiology, Worldwide Regulatory and Safety

Katrina  Mott, MHS

FDA Sentinel Initiative: Status Update

Katrina Mott, MHS

FDA, United States

Andres  Gomez, PhD, MPH

Partnerships Between Pharma and Database Owners

Andres Gomez, PhD, MPH

Bristol-Myers Squibb, United States

Vice President, Head of Epidemiology, Safety Science, and Analytics

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.